Legal Drugs, Illegal Purposes: The Escalating Abuse of Prescription Medications : Hearing Before the Committee on Governmental Affairs, United States Senate, One Hundred Eighth Congress, First Session, August 6, 2003, Field Hearing in Bangor, Maine

Front Cover

What people are saying - Write a review

We haven't found any reviews in the usual places.

Other editions - View all

Common terms and phrases

Popular passages

Page 87 - FDA Talk Papers are prepared by the Press Office to guide FDA personnel in responding with consistency and accuracy to questions from the public on subjects of current interest. Talk Papers are subject to change as more information becomes available.
Page 30 - I would like to thank you for your time and I am willing to answer any questions that you may have. Chairman COLLINS. Thank you very much, Detective.
Page 41 - I want to thank you very much for being with us today and giving us the benefit of your wisdom.
Page 140 - The disease or injury that initiated the train of morbid events leading directly to death or the circumstances of the accident or violence which produced the fatal injury. The underlying cause of death is used as the basis for tabulation of mortality statistics (see CONTRIBUTORY CAUSE OF DEATH).
Page 1 - Committee met, pursuant to notice, at 10:03 am, in room SD-342, Dirksen Senate Office Building, Hon. Susan M. Collins, Chairman of the Committee, presiding. Present: Senators Collins, Coleman, Bennett, Domenici, Warner, Lieberman, Levin, Akaka, Dayton, Carper, and Lautenberg.
Page 16 - I just want to make sure I understand what you are saying.
Page 119 - He was the first post-doctoral fellow at the Margaret Chase Smith Center for Public Policy at the University of Maine and is now an Assistant Professor of Geography at the University of South Florida. His most recent related publications include "Schefferville: The Crisis in the Quebec-Labrador Iron Mining Region
Page 99 - Substance abuse should be accorded parity with other chronic, relapsing conditions insofar as access to care, treatment benefits, and clinical outcomes are concerned.
Page 21 - Gentlemen, thank you very much for being with us this morning. We will put your entire statements in the record and ask that you summarize so we can have a little more time for questions and answers.

Bibliographic information